Cover Image
市場調查報告書

子宮頸癌:全球臨床實驗回顧

Cervical Cancer Global Clinical Trials Review, H1, 2016

出版商 GlobalData 商品編碼 212843
出版日期 內容資訊 英文 515 Pages
訂單完成後即時交付
價格
Back to Top
子宮頸癌:全球臨床實驗回顧 Cervical Cancer Global Clinical Trials Review, H1, 2016
出版日期: 2016年05月19日 內容資訊: 英文 515 Pages
簡介

本報告提供子宮頸癌治療藥物的臨床實驗資料,彙整各國的趨勢,臨床實驗數,全球各臨床實驗所的募集情形等資料,為您概述為以下內容。

目錄

  • 目錄
  • 表格一覽
  • 圖表一覽
  • 簡介
  • 子宮頸癌
  • 報告指南
  • 臨床實驗 各領域
  • 臨床實驗 各國
  • 對臨床實驗有所貢獻的前五國 - 亞太地區
  • 對臨床實驗有所貢獻的前五國 - 歐洲
  • 對臨床實驗有所貢獻的前幾名國家 - 北美
  • 對臨床實驗有所貢獻的前五國 - 中東及非洲
  • 對臨床實驗有所貢獻的前五國 - 中南美
  • 臨床實驗; 金磚四國 各國
  • 臨床實驗; G7 各國
  • 臨床實驗 - G7 各國 各臨床實驗狀態
  • 臨床實驗; E7 各國
  • 臨床實驗 - E7 各國 各臨床實驗狀態
  • 臨床實驗 各方面
  • 進展中臨床實驗 各方面
  • 臨床實驗 各臨床實驗狀態
  • 未完成的臨床實驗; 子宮頸癌
  • 每段時期的實驗人數
  • 有力的贊助商
  • 參加前幾名企業 - 子宮頸癌 治療藥物臨床實驗
  • 潛力治療藥物比較
  • 臨床實驗 簡介
  • 臨床實驗概要; 前幾名企業
  • GlaxoSmithKline plc
  • 臨床實驗概要; GlaxoSmithKline plc
  • Merck & Co., Inc.
  • 臨床實驗概要; Merck & Co., Inc.
  • Photocure ASA
  • 臨床實驗概要; Photocure ASA
  • Pfizer Inc.
  • 臨床實驗概要; Pfizer Inc.
  • Tigris Pharmaceuticals, Inc.
  • 臨床實驗概要; Tigris Pharmaceuticals, Inc.
  • N.V. Mithra Pharmaceuticals S.A.
  • 臨床實驗概要; N.V. Mithra Pharmaceuticals S.A.
  • ARCAGY - GINECO
  • 臨床實驗概要; ARCAGY - GINECO
  • MannKind Corporation
  • 臨床實驗概要; MannKind Corporation
  • Zeria Pharmaceutical Co Ltd
  • 臨床實驗概要; Zeria Pharmaceutical Co Ltd
  • Taiho Pharmaceutical Co., Ltd.
  • 臨床實驗概要; Taiho Pharmaceutical Co., Ltd.
  • Nippon Kayaku Co., Ltd.
  • 臨床實驗概要; Nippon Kayaku Co., Ltd.
  • Novartis AG
  • 臨床實驗概要; Novartis AG
  • VGX Pharmaceuticals Inc.
  • 臨床實驗概要; VGX Pharmaceuticals Inc.
  • Precision Therapeutics , Inc.
  • 臨床實驗概要; Precision Therapeutics , Inc.
  • Cytokine PharmaSciences, Inc.
  • 臨床實驗概要; Cytokine PharmaSciences, Inc.
  • Daiichi Sankyo Company, Ltd
  • 臨床實驗概要; Daiichi Sankyo Company, Ltd
  • GUIDED Therapeutics , Inc.
  • 臨床實驗概要; GUIDED Therapeutics , Inc.
  • Inovio Pharmaceuticals, Inc.
  • 臨床實驗概要; Inovio Pharmaceuticals, Inc.
  • Eli Lilly and Company
  • 臨床實驗概要; Eli Lilly and Company
  • Adherex Technologies Inc.
  • 臨床實驗概要; Adherex Technologies Inc.
  • 臨床實驗概要; 最高級大學 / 研究機關 / 醫院
  • Gynecologic Oncology Group
  • 臨床實驗概要; Gynecologic Oncology Group
  • The University of Texas M. D. Anderson Cancer Center
  • 臨床實驗概要; The University of Texas M. D. Anderson Cancer Center
  • Memorial Sloan Kettering Cancer Center
  • 臨床實驗概要; Memorial Sloan Kettering Cancer Center
  • 歐洲an Organization for Research and Treatment of Cancer
  • 臨床實驗概要; 歐洲an Organization for Research and Treatment of Cancer
  • University Health Network
  • 臨床實驗概要; University Health Network
  • Tata Memorial Hospital
  • 臨床實驗概要; 對Tata Memorial Hospital
  • British Columbia Cancer Agency
  • 臨床實驗概要; British Columbia Cancer Agency
  • Case Comprehensive Cancer Center
  • 臨床實驗概要; Case Comprehensive Cancer Center
  • Washington University School of Medicine
  • 臨床實驗概要; Washington University School of Medicine
  • Wake Forest University
  • 臨床實驗概要; Wake Forest University
  • University of California, Irvine
  • 臨床實驗概要; University of California, Irvine
  • Medical University of Vienna
  • 臨床實驗概要; Medical University of Vienna
  • Masonic Cancer Center
  • 臨床實驗概要; Masonic Cancer Center
  • Duke University
  • 臨床實驗概要; Duke University
  • Dana-Farber Cancer Institute
  • 臨床實驗概要; Dana-Farber Cancer Institute
  • Radiation Therapy Oncology Group
  • 臨床實驗概要; Radiation Therapy Oncology Group
  • The University of British Columbia
  • 臨床實驗概要; The University of British Columbia
  • Chang Gung Memorial Hospital
  • 臨床實驗概要; Chang Gung Memorial Hospital
  • Abramson Cancer Center
  • 臨床實驗概要; Abramson Cancer Center
  • University of Alabama at Birmingham
  • 臨床實驗概要; University of Alabama at Birmingham
  • 主要的 臨床實驗簡介
  • 附錄
  • 簡稱
  • 定義
  • 調查方法
  • 二級研究
  • GlobalData
  • 諮詢方式
  • 免責聲明
  • 資訊來源

表格一覽

  • 子宮頸癌 全球治療藥物市場, 臨床實驗 各地區
  • 子宮頸癌 全球治療藥物市場, 臨床實驗 各國排名
  • 子宮頸癌 全球治療藥物市場, 進展中的臨床實驗 各國排名
  • 子宮頸癌 治療藥物臨床實驗, 亞太地區, 前五國
  • 子宮頸癌 治療藥物臨床實驗, 歐洲, 前五國
  • 子宮頸癌 治療藥物臨床實驗, 北美, 前幾名國家
  • 子宮頸癌 治療藥物臨床實驗, 中東及非洲, 前五國
  • 子宮頸癌 治療藥物臨床實驗, 中南美, 前五國
  • 子宮頸癌 治療藥物臨床實驗, 金磚四國 各國
  • 子宮頸癌 治療藥物臨床實驗, G7 各國
  • 子宮頸癌 治療藥物市場, G7 各國, 臨床實驗 各臨床實驗狀態
  • 子宮頸癌 治療藥物臨床實驗, E7 各國
  • 子宮頸癌 治療藥物市場, E7 各國, 臨床實驗 各臨床實驗狀態
  • 子宮頸癌 全球治療藥物市場, 臨床實驗 各方面
  • 子宮頸癌 全球治療藥物市場, 進展中的臨床實驗 各方面
  • 子宮頸癌 全球治療藥物市場, 臨床實驗 各臨床實驗狀態
  • 子宮頸癌 全球治療藥物市場, 一時中止的臨床實驗
  • 子宮頸癌 全球治療藥物市場, 中止的臨床實驗
  • 子宮頸癌 全球治療藥物市場, 結束的臨床實驗
  • 子宮頸癌 全球治療藥物臨床實驗, 平均登錄對象人數趨勢
  • 子宮頸癌 全球治療藥物臨床實驗, 主要贊助商
  • 子宮頸癌 全球治療藥物臨床實驗, 前幾名企業 各方面
  • 子宮頸癌 全球治療藥物臨床實驗, 臨床實驗; 潛力治療藥物
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; GlaxoSmithKline plc
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; Merck & Co., Inc.
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; Photocure ASA
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; Pfizer Inc.
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; Tigris Pharmaceuticals, Inc.
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; N.V. Mithra Pharmaceuticals S.A.
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; ARCAGY - GINECO
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; MannKind Corporation
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; Zeria Pharmaceutical Co Ltd
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; Taiho Pharmaceutical Co., Ltd.
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; Nippon Kayaku Co., Ltd.
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; Novartis AG
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; VGX Pharmaceuticals Inc.
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; Precision Therapeutics , Inc.
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; Cytokine PharmaSciences, Inc.
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; Daiichi Sankyo Company, Ltd
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; GUIDED Therapeutics , Inc.
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; Inovio Pharmaceuticals, Inc.
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; Eli Lilly and Company
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; Adherex Technologies Inc.
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; Gynecologic Oncology Group
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; The University of Texas M. D. Anderson Cancer Center
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; Memorial Sloan Kettering Cancer Center
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; 歐洲an Organization for Research and Treatment of Cancer
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; University Health Network
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; 對Tata Memorial Hospital
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; British Columbia Cancer Agency
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; Case Comprehensive Cancer Center
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; Washington University School of Medicine
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; Wake Forest University
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; University of California, Irvine
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; Medical University of Vienna
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; Masonic Cancer Center
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; Duke University
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; Dana-Farber Cancer Institute
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; Radiation Therapy Oncology Group
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; The University of British Columbia
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; Chang Gung Memorial Hospital
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; Abramson Cancer Center
  • 子宮頸癌 全球治療藥物臨床實驗市場, 臨床實驗; University of Alabama at Birmingham

圖表一覽

  • 子宮頸癌 全球治療藥物市場, 臨床實驗 各地區 (%)
  • 子宮頸癌 全球治療藥物市場, 臨床實驗 各國排名
  • 子宮頸癌 全球治療藥物市場, 進展中的臨床實驗 各國排名
  • 子宮頸癌 治療藥物臨床實驗, 亞太地區, 前五國 (%)
  • 子宮頸癌 治療藥物臨床實驗, 歐洲, 前五國 (%)
  • 子宮頸癌 治療藥物臨床實驗, 北美, 前幾名國家 (%)
  • 子宮頸癌 治療藥物臨床實驗, 中東及非洲, 前五國 (%)
  • 子宮頸癌 治療藥物臨床實驗, 中南美, 前五國 (%)
  • 子宮頸癌 治療藥物臨床實驗, 金磚四國 各國 (%)
  • 子宮頸癌 治療藥物臨床實驗, G7 各國 (%)
  • 子宮頸癌 治療藥物市場, G7 各國, 臨床實驗 各臨床實驗狀態
  • 子宮頸癌 治療藥物臨床實驗, E7 各國 (%)
  • 子宮頸癌 治療藥物市場, E7 各國, 臨床實驗 各臨床實驗狀態
  • 子宮頸癌 全球治療藥物市場, 臨床實驗 各方面 (%)
  • 子宮頸癌 全球治療藥物市場, 進展中的臨床實驗 各方面
  • 子宮頸癌 全球治療藥物市場, 臨床實驗 各臨床實驗狀態
  • 子宮頸癌 全球治療藥物臨床實驗, 平均登錄對象人數趨勢
  • 子宮頸癌 全球治療藥物臨床實驗, 主要贊助商
  • 子宮頸癌 全球治療藥物臨床實驗, 前幾名企業 各方面
  • 子宮頸癌 全球治療藥物臨床實驗, 臨床實驗; 潛力治療藥物
  • GlobalData 調查方法

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3401CTIDB

GlobalData's clinical trial report, "Cervical Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Cervical Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Cervical Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Cervical Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Cervical Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Cervical Cancer Therapeutics Clinical Trials
  • Prominent Drugs
    • Latest Clinical Trials News on Cervical Cancer
      • Apr 25, 2016: Phase II Cervical Cancer Study with Advaxis' Axalimogene Filolisbac Selected for Poster Discussion Session at the 2016 ASCO Annual Meeting
      • Apr 18, 2016: New HPV vaccine could curb cervical cancers and health costs if adopted widely
      • Mar 29, 2016: Inovio Updates INO-3112 HPV Immunotherapy Development Plan
      • Mar 29, 2016: Advaxis Combination Trial with MedImmune Completes First Dose-Escalation Cohort
      • Mar 07, 2016: Dosing Begins in High Dose Expansion Cohort in Phase 2 Study of Axalimogene Filolisbac in Patients With Recurrent Cervical Cancer
      • Mar 04, 2016: Karyopharm's Selinexor First-in-Human Phase 1 Clinical Trial Data Published in Journal of Clinical Oncology
      • Mar 02, 2016: New trial launched to test cancer vaccine
      • Feb 11, 2016: Navidea Biopharmaceuticals Enrolls First Patient in Cervical Cancer Study of Lymphoseek
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Cervical Cancer Therapeutics, Global, Clinical Trials by Region, 2016*
  • Cervical Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Cervical Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Cervical Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016*
  • Cervical Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2016*
  • Cervical Cancer Therapeutics Clinical Trials, North America, Top Countries, 2016*
  • Cervical Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016*
  • Cervical Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016*
  • Proportion of Cervical Cancer to Oncology Clinical Trials, G7 Countries (%), 2016*
  • Cervical Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Cervical Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Cervical Cancer to Oncology Clinical Trials, E7 Countries (%), 2016*
  • Cervical Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Cervical Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Cervical Cancer Therapeutics, Global, Clinical Trials by Phase, 2016*
  • Cervical Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2016*
  • Cervical Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Cervical Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Cervical Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Cervical Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016*
  • Cervical Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Cervical Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Cervical Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*

List of Figures

  • Cervical Cancer Therapeutics, Global, Clinical Trials by Region (%), 2016*
  • Cervical Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Cervical Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Cervical Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016*
  • Cervical Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016*
  • Cervical Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2016*
  • Cervical Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016*
  • Cervical Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016*
  • Proportion of Cervical Cancer to Oncology Clinical Trials, G7 Countries (%), 2016*
  • Cervical Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Cervical Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Cervical Cancer to Oncology Clinical Trials, E7 Countries (%), 2016*
  • Cervical Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Cervical Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Cervical Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2016*
  • Cervical Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2016*
  • Cervical Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Cervical Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Cervical Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Cervical Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016*
  • Cervical Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Cervical Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Cervical Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*
  • GlobalData Methodology
Back to Top